Literature DB >> 12604839

Influence of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the antigen-presenting activity of dendritic cells.

Beth A Vorderstrasse1, Erica A Dearstyne, Nancy I Kerkvliet.   

Abstract

We have previously shown that exposure of mice to 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) induces activation-like changes in splenic dendritic cells (DC) in the absence of antigen challenge. Since activation of DC reduces their ability to phagocytize antigen, we examined the effects of TCDD on the ability of DC to process and present antigen to antigen-specific T cells and to internalize latex beads. Additionally, the expression of costimulatory and adhesion molecules was examined on DC from TCDD-treated mice injected with allogeneic tumor cells. The ability of DC from C57Bl/6 mice to induce proliferation of keyhole limpet hemocyanin (KLH)-specific 10.5.17 T cells and production of IL-4 was not significantly altered by TCDD exposure, either when KLH was added in vitro or when the mice were injected with KLH prior to DC isolation. In contrast, ovalbumin (OVA) presentation by DC from TCDD-treated Balb/c mice induced enhanced proliferation of OVA-specific D011.10 T cells, although the production of IL-2 and IFN-gamma was not affected. Enhanced in vivo proliferation of adoptively transferred, CFSE-labeled DO11.10 T cells was also observed in TCDD-treated Balb/c mice that were challenged with OVA. TCDD treatment modulated the expression of major histocompatibility complex (MHC) class II, CD24, ICAM-1, CD40, and LFA-1 on splenic DC from C57Bl/6 mice injected with allogeneic tumor cells; however, the effects of TCDD were identical to changes seen previously in nonimmune mice, suggesting that these effects were not antigen-dependent. Finally, TCDD treatment did not affect the ability of splenic DC to internalize latex beads administered in vivo. Taken together, these results suggest that the activation-like changes induced in DC by TCDD do not suppress the ability of DC to process and present antigen, but may enhance their ability to provide activation signals to T cells. This, in turn, may alter the survival of the T cells, the DC, or both, and might lead to dysregulation of the immune response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604839     DOI: 10.1093/toxsci/kfg012

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  15 in total

1.  Consequences of AhR activation in steady-state dendritic cells.

Authors:  Tom Simones; David M Shepherd
Journal:  Toxicol Sci       Date:  2010-11-19       Impact factor: 4.849

2.  Activation of the arylhydrocarbon receptor causes immunosuppression primarily by modulating dendritic cells.

Authors:  Anika Bruhs; Thomas Haarmann-Stemmann; Katrin Frauenstein; Jean Krutmann; Thomas Schwarz; Agatha Schwarz
Journal:  J Invest Dermatol       Date:  2014-09-24       Impact factor: 8.551

3.  Functional and phenotypic effects of AhR activation in inflammatory dendritic cells.

Authors:  Jaishree Bankoti; Ben Rase; Tom Simones; David M Shepherd
Journal:  Toxicol Appl Pharmacol       Date:  2010-03-27       Impact factor: 4.219

4.  Effects of TCDD on the fate of naive dendritic cells.

Authors:  Jaishree Bankoti; Andrea Burnett; Severine Navarro; Andrea K Miller; Ben Rase; David M Shepherd
Journal:  Toxicol Sci       Date:  2010-03-08       Impact factor: 4.849

Review 5.  Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells.

Authors:  Nikki B Marshall; Nancy I Kerkvliet
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

6.  Aryl hydrocarbon receptor activation reduces dendritic cell function during influenza virus infection.

Authors:  Guang-Bi Jin; Amanda J Moore; Jennifer L Head; Joshua J Neumiller; B Paige Lawrence
Journal:  Toxicol Sci       Date:  2010-05-23       Impact factor: 4.849

Review 7.  A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family.

Authors:  Christoph F A Vogel; Fumio Matsumura
Journal:  Biochem Pharmacol       Date:  2008-10-08       Impact factor: 5.858

8.  Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound.

Authors:  B Paige Lawrence; Michael S Denison; Hermann Novak; Beth A Vorderstrasse; Nathalie Harrer; Wolfgang Neruda; Claudia Reichel; Maximilian Woisetschläger
Journal:  Blood       Date:  2008-02-12       Impact factor: 22.113

9.  Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters postnatal T cell phenotypes and T cell function and exacerbates autoimmune lupus in 24-week-old SNF1 mice.

Authors:  Amjad Mustafa; Steven D Holladay; Matthew Goff; Sharon Witonsky; Richard Kerr; Danielle A Weinstein; Ebru Karpuzoglu-Belgin; Robert M Gogal
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-10

Review 10.  AHR-mediated immunomodulation: the role of altered gene transcription.

Authors:  Nancy I Kerkvliet
Journal:  Biochem Pharmacol       Date:  2008-11-27       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.